Click for best price
Pediatric Drugs Vaccines Market Size, Share 2022
Market Analysis and Insights: Global Pediatric Drugs Vaccines Market
The global Pediatric Drugs Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Drugs Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Drugs Vaccines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Drugs Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Drugs Vaccines market.
Global Pediatric Drugs Vaccines Scope and Market Size
Pediatric Drugs and Vaccines market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Pediatric Drugs and Vaccines market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application
Newborn
Infant
Child
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Pediatric Drugs Vaccines product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Pediatric Drugs Vaccines, with price, sales, revenue, and global market share of Pediatric Drugs Vaccines from 2019 to 2022.
Chapter 3, the Pediatric Drugs Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pediatric Drugs Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Pediatric Drugs Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pediatric Drugs Vaccines.
Chapter 13, 14, and 15, to describe Pediatric Drugs Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Pediatric Drugs Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Pediatric Drugs and Vaccines Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
112 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Pediatric Drugs and Vaccines Product Introduction
1.2 Global Pediatric Drugs and Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pediatric Drugs and Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Pediatric Drugs and Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Pediatric Drugs and Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Pediatric Drugs and Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Pediatric Drugs and Vaccines Sales in Volume for the Year 2017-2028
1.4 Pediatric Drugs and Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Pediatric Drugs and Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Pediatric Drugs and Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Pediatric Drugs and Vaccines Market Dynamics
1.5.1 Pediatric Drugs and Vaccines Industry Trends
1.5.2 Pediatric Drugs and Vaccines Market Drivers
1.5.3 Pediatric Drugs and Vaccines Market Challenges
1.5.4 Pediatric Drugs and Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Pediatric Drugs and Vaccines Market Segment by Type
2.1.1 Diphtheria
2.1.2 Influenza
2.1.3 Hepatitis
2.1.4 Pneumococcal Diseases
2.1.5 Meningococcal Diseases
2.1.6 Mumps
2.1.7 Others
2.2 Global Pediatric Drugs and Vaccines Market Size by Type
2.2.1 Global Pediatric Drugs and Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Pediatric Drugs and Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Pediatric Drugs and Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Pediatric Drugs and Vaccines Market Size by Type
2.3.1 United States Pediatric Drugs and Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Pediatric Drugs and Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Pediatric Drugs and Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Pediatric Drugs and Vaccines Market Segment by Application
3.1.1 Newborn
3.1.2 Infant
3.1.3 Child
3.2 Global Pediatric Drugs and Vaccines Market Size by Application
3.2.1 Global Pediatric Drugs and Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Pediatric Drugs and Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Pediatric Drugs and Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Pediatric Drugs and Vaccines Market Size by Application
3.3.1 United States Pediatric Drugs and Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Pediatric Drugs and Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Pediatric Drugs and Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pediatric Drugs and Vaccines Competitor Landscape by Company
4.1 Global Pediatric Drugs and Vaccines Market Size by Company
4.1.1 Top Global Pediatric Drugs and Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Pediatric Drugs and Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Pediatric Drugs and Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Pediatric Drugs and Vaccines Price by Manufacturer (2017-2022)
4.2 Global Pediatric Drugs and Vaccines Concentration Ratio (CR)
4.2.1 Pediatric Drugs and Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pediatric Drugs and Vaccines in 2021
4.2.3 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pediatric Drugs and Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Pediatric Drugs and Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Pediatric Drugs and Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Pediatric Drugs and Vaccines Market Size by Company
4.5.1 Top Pediatric Drugs and Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pediatric Drugs and Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Pediatric Drugs and Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Pediatric Drugs and Vaccines Market Size by Region
5.1 Global Pediatric Drugs and Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pediatric Drugs and Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Pediatric Drugs and Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Pediatric Drugs and Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Pediatric Drugs and Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Pediatric Drugs and Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Pediatric Drugs and Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pediatric Drugs and Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Pediatric Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pediatric Drugs and Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pediatric Drugs and Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pediatric Drugs and Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Pediatric Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pediatric Drugs and Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Merck & Co., Inc. (USA)
7.1.1 Merck & Co., Inc. (USA) Corporation Information
7.1.2 Merck & Co., Inc. (USA) Description and Business Overview
7.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
7.1.5 Merck & Co., Inc. (USA) Recent Development
7.2 Abbott Laboratories (USA)
7.2.1 Abbott Laboratories (USA) Corporation Information
7.2.2 Abbott Laboratories (USA) Description and Business Overview
7.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
7.2.5 Abbott Laboratories (USA) Recent Development
7.3 Amgen, Inc. (USA)
7.3.1 Amgen, Inc. (USA) Corporation Information
7.3.2 Amgen, Inc. (USA) Description and Business Overview
7.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
7.3.5 Amgen, Inc. (USA) Recent Development
7.4 Eli Lilly and Company (USA)
7.4.1 Eli Lilly and Company (USA) Corporation Information
7.4.2 Eli Lilly and Company (USA) Description and Business Overview
7.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
7.4.5 Eli Lilly and Company (USA) Recent Development
7.5 F. Hoffmann-La Roche Ltd (Switzerland)
7.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
7.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
7.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
7.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
7.6 Genentech, Inc. (USA)
7.6.1 Genentech, Inc. (USA) Corporation Information
7.6.2 Genentech, Inc. (USA) Description and Business Overview
7.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
7.6.5 Genentech, Inc. (USA) Recent Development
7.7 GlaxoSmithKline plc. (UK)
7.7.1 GlaxoSmithKline plc. (UK) Corporation Information
7.7.2 GlaxoSmithKline plc. (UK) Description and Business Overview
7.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
7.7.5 GlaxoSmithKline plc. (UK) Recent Development
7.8 Janssen Biologics B.V. (USA)
7.8.1 Janssen Biologics B.V. (USA) Corporation Information
7.8.2 Janssen Biologics B.V. (USA) Description and Business Overview
7.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
7.8.5 Janssen Biologics B.V. (USA) Recent Development
7.9 Actelion Pharmaceuticals
7.9.1 Actelion Pharmaceuticals Corporation Information
7.9.2 Actelion Pharmaceuticals Description and Business Overview
7.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
7.9.5 Actelion Pharmaceuticals Recent Development
7.10 AstraZeneca Plc. (UK)
7.10.1 AstraZeneca Plc. (UK) Corporation Information
7.10.2 AstraZeneca Plc. (UK) Description and Business Overview
7.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
7.10.5 AstraZeneca Plc. (UK) Recent Development
7.11 Boehringer Ingelheim GmbH (Germany)
7.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
7.11.2 Boehringer Ingelheim GmbH (Germany) Description and Business Overview
7.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Products Offered
7.11.5 Boehringer Ingelheim GmbH (Germany) Recent Development
7.12 Bristol-Myers Squibb Company (USA)
7.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
7.12.2 Bristol-Myers Squibb Company (USA) Description and Business Overview
7.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Bristol-Myers Squibb Company (USA) Products Offered
7.12.5 Bristol-Myers Squibb Company (USA) Recent Development
7.13 Allergan, Inc. (USA)
7.13.1 Allergan, Inc. (USA) Corporation Information
7.13.2 Allergan, Inc. (USA) Description and Business Overview
7.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Allergan, Inc. (USA) Products Offered
7.13.5 Allergan, Inc. (USA) Recent Development
7.14 Novartis AG (Switzerland)
7.14.1 Novartis AG (Switzerland) Corporation Information
7.14.2 Novartis AG (Switzerland) Description and Business Overview
7.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Novartis AG (Switzerland) Products Offered
7.14.5 Novartis AG (Switzerland) Recent Development
7.15 Novo Nordisk A/S (Denmark)
7.15.1 Novo Nordisk A/S (Denmark) Corporation Information
7.15.2 Novo Nordisk A/S (Denmark) Description and Business Overview
7.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Novo Nordisk A/S (Denmark) Products Offered
7.15.5 Novo Nordisk A/S (Denmark) Recent Development
7.16 Pfizer, Inc. (USA)
7.16.1 Pfizer, Inc. (USA) Corporation Information
7.16.2 Pfizer, Inc. (USA) Description and Business Overview
7.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Pfizer, Inc. (USA) Products Offered
7.16.5 Pfizer, Inc. (USA) Recent Development
7.17 Sanofi S.A (France)
7.17.1 Sanofi S.A (France) Corporation Information
7.17.2 Sanofi S.A (France) Description and Business Overview
7.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Sanofi S.A (France) Products Offered
7.17.5 Sanofi S.A (France) Recent Development
7.18 Shionogi Inc. (USA)
7.18.1 Shionogi Inc. (USA) Corporation Information
7.18.2 Shionogi Inc. (USA) Description and Business Overview
7.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Shionogi Inc. (USA) Products Offered
7.18.5 Shionogi Inc. (USA) Recent Development
7.19 Takeda
7.19.1 Takeda Corporation Information
7.19.2 Takeda Description and Business Overview
7.19.3 Takeda Pediatric Drugs and Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Takeda Products Offered
7.19.5 Takeda Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Pediatric Drugs and Vaccines Industry Chain Analysis
8.2 Pediatric Drugs and Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Pediatric Drugs and Vaccines Distributors
8.3 Pediatric Drugs and Vaccines Production Mode & Process
8.4 Pediatric Drugs and Vaccines Sales and Marketing
8.4.1 Pediatric Drugs and Vaccines Sales Channels
8.4.2 Pediatric Drugs and Vaccines Distributors
8.5 Pediatric Drugs and Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pediatric Drugs and Vaccines CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Pediatric Drugs and Vaccines Market Trends
Table 3. Pediatric Drugs and Vaccines Market Drivers
Table 4. Pediatric Drugs and Vaccines Market Challenges
Table 5. Pediatric Drugs and Vaccines Market Restraints
Table 6. Global Pediatric Drugs and Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pediatric Drugs and Vaccines Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pediatric Drugs and Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pediatric Drugs and Vaccines Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pediatric Drugs and Vaccines Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Pediatric Drugs and Vaccines Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturer, 2017-2022
Table 13. Global Pediatric Drugs and Vaccines Sales by Manufacturer, (Kg), 2017-2022
Table 14. Global Pediatric Drugs and Vaccines Sales Share by Manufacturer, 2017-2022
Table 15. Global Pediatric Drugs and Vaccines Price by Manufacturer (2017-2022) & (USD/Kg)
Table 16. Global Pediatric Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Pediatric Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2021)
Table 18. Top Players of Pediatric Drugs and Vaccines in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Pediatric Drugs and Vaccines Product Type
Table 20. Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Pediatric Drugs and Vaccines Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Pediatric Drugs and Vaccines Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Pediatric Drugs and Vaccines Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Pediatric Drugs and Vaccines Sales by Players, (Kg), 2020, 2021 & 2022
Table 26. United States Pediatric Drugs and Vaccines Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Pediatric Drugs and Vaccines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Pediatric Drugs and Vaccines Sales in Volume by Region (2017-2022) & (Kg)
Table 29. Global Pediatric Drugs and Vaccines Sales in Volume Forecast by Region (2023-2028) & (Kg)
Table 30. Global Pediatric Drugs and Vaccines Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Pediatric Drugs and Vaccines Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Pediatric Drugs and Vaccines Sales in Volume by Country (2017-2028) & (Kg)
Table 33. North America Pediatric Drugs and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Pediatric Drugs and Vaccines Sales in Volume by Region (2017-2028) & (Kg)
Table 35. Asia Pacific Pediatric Drugs and Vaccines Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Pediatric Drugs and Vaccines Sales in Volume by Country (2017-2028) & (Kg)
Table 37. Europe Pediatric Drugs and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Pediatric Drugs and Vaccines Sales in Volume by Country (2017-2028) & (Kg)
Table 39. Latin Americaa Pediatric Drugs and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Pediatric Drugs and Vaccines Sales in Volume by Country (2017-2028) & (Kg)
Table 41. Middle East and Africa Pediatric Drugs and Vaccines Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Merck & Co., Inc. (USA) Corporation Information
Table 43. Merck & Co., Inc. (USA) Description and Business Overview
Table 44. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 45. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product
Table 46. Merck & Co., Inc. (USA) Recent Development
Table 47. Abbott Laboratories (USA) Corporation Information
Table 48. Abbott Laboratories (USA) Description and Business Overview
Table 49. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 50. Abbott Laboratories (USA) Product
Table 51. Abbott Laboratories (USA) Recent Development
Table 52. Amgen, Inc. (USA) Corporation Information
Table 53. Amgen, Inc. (USA) Description and Business Overview
Table 54. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 55. Amgen, Inc. (USA) Product
Table 56. Amgen, Inc. (USA) Recent Development
Table 57. Eli Lilly and Company (USA) Corporation Information
Table 58. Eli Lilly and Company (USA) Description and Business Overview
Table 59. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 60. Eli Lilly and Company (USA) Product
Table 61. Eli Lilly and Company (USA) Recent Development
Table 62. F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
Table 63. F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
Table 64. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 65. F. Hoffmann-La Roche Ltd (Switzerland) Product
Table 66. F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
Table 67. Genentech, Inc. (USA) Corporation Information
Table 68. Genentech, Inc. (USA) Description and Business Overview
Table 69. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 70. Genentech, Inc. (USA) Product
Table 71. Genentech, Inc. (USA) Recent Development
Table 72. GlaxoSmithKline plc. (UK) Corporation Information
Table 73. GlaxoSmithKline plc. (UK) Description and Business Overview
Table 74. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 75. GlaxoSmithKline plc. (UK) Product
Table 76. GlaxoSmithKline plc. (UK) Recent Development
Table 77. Janssen Biologics B.V. (USA) Corporation Information
Table 78. Janssen Biologics B.V. (USA) Description and Business Overview
Table 79. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 80. Janssen Biologics B.V. (USA) Product
Table 81. Janssen Biologics B.V. (USA) Recent Development
Table 82. Actelion Pharmaceuticals Corporation Information
Table 83. Actelion Pharmaceuticals Description and Business Overview
Table 84. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 85. Actelion Pharmaceuticals Product
Table 86. Actelion Pharmaceuticals Recent Development
Table 87. AstraZeneca Plc. (UK) Corporation Information
Table 88. AstraZeneca Plc. (UK) Description and Business Overview
Table 89. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 90. AstraZeneca Plc. (UK) Product
Table 91. AstraZeneca Plc. (UK) Recent Development
Table 92. Boehringer Ingelheim GmbH (Germany) Corporation Information
Table 93. Boehringer Ingelheim GmbH (Germany) Description and Business Overview
Table 94. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 95. Boehringer Ingelheim GmbH (Germany) Product
Table 96. Boehringer Ingelheim GmbH (Germany) Recent Development
Table 97. Bristol-Myers Squibb Company (USA) Corporation Information
Table 98. Bristol-Myers Squibb Company (USA) Description and Business Overview
Table 99. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 100. Bristol-Myers Squibb Company (USA) Product
Table 101. Bristol-Myers Squibb Company (USA) Recent Development
Table 102. Allergan, Inc. (USA) Corporation Information
Table 103. Allergan, Inc. (USA) Description and Business Overview
Table 104. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 105. Allergan, Inc. (USA) Product
Table 106. Allergan, Inc. (USA) Recent Development
Table 107. Novartis AG (Switzerland) Corporation Information
Table 108. Novartis AG (Switzerland) Description and Business Overview
Table 109. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 110. Novartis AG (Switzerland) Product
Table 111. Novartis AG (Switzerland) Recent Development
Table 112. Novo Nordisk A/S (Denmark) Corporation Information
Table 113. Novo Nordisk A/S (Denmark) Description and Business Overview
Table 114. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 115. Novo Nordisk A/S (Denmark) Product
Table 116. Novo Nordisk A/S (Denmark) Recent Development
Table 117. Pfizer, Inc. (USA) Corporation Information
Table 118. Pfizer, Inc. (USA) Description and Business Overview
Table 119. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 120. Pfizer, Inc. (USA) Product
Table 121. Pfizer, Inc. (USA) Recent Development
Table 122. Sanofi S.A (France) Corporation Information
Table 123. Sanofi S.A (France) Description and Business Overview
Table 124. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 125. Sanofi S.A (France) Product
Table 126. Sanofi S.A (France) Recent Development
Table 127. Shionogi Inc. (USA) Corporation Information
Table 128. Shionogi Inc. (USA) Description and Business Overview
Table 129. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 130. Shionogi Inc. (USA) Product
Table 131. Shionogi Inc. (USA) Recent Development
Table 132. Takeda Corporation Information
Table 133. Takeda Description and Business Overview
Table 134. Takeda Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 135. Takeda Product
Table 136. Takeda Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Pediatric Drugs and Vaccines Customers List
Table 140. Pediatric Drugs and Vaccines Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Drugs and Vaccines Product Picture
Figure 2. Global Pediatric Drugs and Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pediatric Drugs and Vaccines Market Size 2017-2028 (US$ Million)
Figure 4. Global Pediatric Drugs and Vaccines Sales 2017-2028 (Kg)
Figure 5. United States Pediatric Drugs and Vaccines Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Pediatric Drugs and Vaccines Market Size 2017-2028 (US$ Million)
Figure 7. United States Pediatric Drugs and Vaccines Sales 2017-2028 (Kg)
Figure 8. United States Pediatric Drugs and Vaccines Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Pediatric Drugs and Vaccines Market Share in Global, in Volume (Kg) 2017-2028
Figure 10. Pediatric Drugs and Vaccines Report Years Considered
Figure 11. Product Picture of Diphtheria
Figure 12. Product Picture of Influenza
Figure 13. Product Picture of Hepatitis
Figure 14. Product Picture of Pneumococcal Diseases
Figure 15. Product Picture of Meningococcal Diseases
Figure 16. Product Picture of Mumps
Figure 17. Product Picture of Others
Figure 18. Global Pediatric Drugs and Vaccines Market Share by Type in 2022 & 2028
Figure 19. Global Pediatric Drugs and Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 20. Global Pediatric Drugs and Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 21. Global Pediatric Drugs and Vaccines Sales by Type (2017-2028) & (Kg)
Figure 22. Global Pediatric Drugs and Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 23. Global Pediatric Drugs and Vaccines Price by Type (2017-2028) & (USD/Kg)
Figure 24. United States Pediatric Drugs and Vaccines Market Share by Type in 2022 & 2028
Figure 25. United States Pediatric Drugs and Vaccines Sales in Value by Type (2017-2028) & (US$ Million)
Figure 26. United States Pediatric Drugs and Vaccines Sales Market Share in Value by Type (2017-2028)
Figure 27. United States Pediatric Drugs and Vaccines Sales by Type (2017-2028) & (Kg)
Figure 28. United States Pediatric Drugs and Vaccines Sales Market Share in Volume by Type (2017-2028)
Figure 29. United States Pediatric Drugs and Vaccines Price by Type (2017-2028) & (USD/Kg)
Figure 30. Product Picture of Newborn
Figure 31. Product Picture of Infant
Figure 32. Product Picture of Child
Figure 33. Global Pediatric Drugs and Vaccines Market Share by Application in 2022 & 2028
Figure 34. Global Pediatric Drugs and Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. Global Pediatric Drugs and Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 36. Global Pediatric Drugs and Vaccines Sales by Application (2017-2028) & (Kg)
Figure 37. Global Pediatric Drugs and Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 38. Global Pediatric Drugs and Vaccines Price by Application (2017-2028) & (USD/Kg)
Figure 39. United States Pediatric Drugs and Vaccines Market Share by Application in 2022 & 2028
Figure 40. United States Pediatric Drugs and Vaccines Sales in Value by Application (2017-2028) & (US$ Million)
Figure 41. United States Pediatric Drugs and Vaccines Sales Market Share in Value by Application (2017-2028)
Figure 42. United States Pediatric Drugs and Vaccines Sales by Application (2017-2028) & (Kg)
Figure 43. United States Pediatric Drugs and Vaccines Sales Market Share in Volume by Application (2017-2028)
Figure 44. United States Pediatric Drugs and Vaccines Price by Application (2017-2028) & (USD/Kg)
Figure 45. North America Pediatric Drugs and Vaccines Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 46. North America Pediatric Drugs and Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. U.S. Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Canada Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Europe Pediatric Drugs and Vaccines Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 50. Europe Pediatric Drugs and Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 51. Germany Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. France Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. U.K. Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Italy Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Russia Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Asia-Pacific Pediatric Drugs and Vaccines Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 57. Asia-Pacific Pediatric Drugs and Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 58. China Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Japan Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. South Korea Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. India Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Australia Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Taiwan Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Indonesia Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Thailand Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Malaysia Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Philippines Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Latin America Pediatric Drugs and Vaccines Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 69. Latin America Pediatric Drugs and Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 70. Mexico Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Brazil Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Argentina Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Middle East & Africa Pediatric Drugs and Vaccines Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 74. Middle East & Africa Pediatric Drugs and Vaccines Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 75. Turkey Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Saudi Arabia Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 77. U.A.E Pediatric Drugs and Vaccines Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 78. Pediatric Drugs and Vaccines Value Chain
Figure 79. Pediatric Drugs and Vaccines Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
